A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with JIA are at risk of intraocular inflammation (uveitis). In the initial stages of mild-moderate inflammation uveitis is asymptomatic. Most children with mild-moderate uveitis are managed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanan, Athimalaipet V., Dick, Andrew D., Jones, Ashley P., Guly, Catherine, Hardwick, Ben, Hickey, Helen, Lee, Richard, McKay, Andrew, Beresford, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390576/
https://www.ncbi.nlm.nih.gov/pubmed/30886955
http://dx.doi.org/10.1186/s41927-018-0010-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390576/
https://www.ncbi.nlm.nih.gov/pubmed/30886955
http://dx.doi.org/10.1186/s41927-018-0010-2

Ejemplares similares